Table 2.

Associations of baseline TG/HDL-C with incident T2DM.

	Incident T2DM
	Crude Model	Model I	Model II	Model III
	H.R. (95%CI) P-value	H.R. (95%CI) P-value	H.R. (95%CI) P-value	H.R. (95%CI) P-value
TG/HDL-C continuous	1.469 (1.340, 1.610)<0.001	1.301 (1.175, 1.440)<0.001	1.196 (1.073, 1.332) 0.001	1.188 (1.063, 1.327) 0.002
TG/HDL-C quartile
Q1	1.000	1.000	1.000	1.000
Q2	0.755 (0.396, 1.439) 0.393	0.597 (0.313, 1.141) 0.118	0.490 (0.255, 0.941) 0.032	0.486 (0.253, 0.936) 0.031
Q3	1.872 (1.095, 3.201) 0.022	1.214 (0.701, 2.102) 0.488	0.910 (0.520, 1.593) 0.741	0.891 (0.505, 1.573) 0.692
Q4	3.151 (1.910, 5.199)<0.001	1.619 (0.961, 2.727) 0.070	1.050 (0.609, 1.810) 0.861	1.012 (0.578, 1.773) 0.967

Crude model adjusted for None.

Model I adjusted for baseline age and BMI.

Model II adjusted for baseline age, BMI, fatty liver, waist circumference, body weight, exercise habits, alcohol consumption, smoking status, systolic blood pressure, and diastolic blood pressure.

Model III adjusted for baseline age, fatty liver, BMI, waist circumference, body weight, exercise habits, alcohol consumption, smoking status, systolic blood pressure, diastolic blood pressure, total cholesterol, GGT, ALT, and AST.

HR, hazard ratio; CI, confidence intervals; Q, quartile; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transpeptidase; DBP, diastolic blood pressure; SBP, systolic blood pressure; HDL-cholesterol, high-density lipoprotein-cholesterol; TG/HDL-C, triglyceride to high-density lipoprotein cholesterol ratio; BMI, body mass index.